共 8 条
[1]
Cognitive Enhancement: Methods, Ethics, Regulatory Challenges[J] . Nick Bostrom,Anders Sandberg.Science and Engineering Ethics . 2009 (3)
[2]
Oxiracetam prevents the MK-801 induced amnesia for the elevated plus-maze in mice[J] . Behavioural Brain Research . 2000 (1)
[3]
Enhancement of contextual fear-conditioning by putative （±）- α -amino-3-hydroxy-5-methylisoxazole-4-propionic acid （AMPA） receptor modulators and N -methyl- d -aspartate （NMDA） receptor antagonists in DBA/2J mice[J] . Ying Lu,Jeanne M Wehner.Brain Research . 1997 (1)
[4]
Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions[J] . L. Bartolini,F. Casamenti,G. Pepeu.Pharmacology, Biochemistry and Behavior . 1996 (2)
[5]
Effects of nefiracetam, a novel pyrrolidone derivative, on brain monoamine metabolisms in mice[J] . E. Abe,S. Murai,H. Saito,Y. Masuda,T. Itoh.Journal of Neural Transmission . 1992 (2)
[6]
Elevated corticosteroid levels block the memory-improving effects of nootropics and cholinomimetics[J] . Psychopharmacology . 1992 (1)
[7]
Oxiracetam and d -pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl- d -aspartate receptor antagonist 2-amino-5-phosphonovalerate[J] . F. Paoli,G. Spignoli,G. Pepeu.Psychopharmacology . 1990 (1)
[8]
Cholineincorporationinto phospholipids in brain areas fromspontaneously hypertensive rats:effect of oxiracetamtreat ment. Nardella C,Terracina L,Brunetti M,et al. Farmaco . 1991